Building Caregiver Skills Using a Simulation-based Intervention for Care of Head and Neck Cancer

Sponsor
Case Comprehensive Cancer Center (Other)
Overall Status
Completed
CT.gov ID
NCT02577237
Collaborator
(none)
18
1
2
29.4
0.6

Study Details

Study Description

Brief Summary

Patients with head and neck cancer and their caregivers face many challenges. These include learning about cancer and its treatment, coping with symptoms from illness and treatment side effects, making adjustments to usual activities, and managing the emotional effects of having a serious illness. This study tests whether different forms of education and support can help family caregivers feel better prepared. To find out if education about caregiving and different kinds of support are effective, this study wants to compare approaches.One group includes caregivers who will receive an education and support program throughout radiation treatment in addition to usual care by their doctors and nurses. The other group receives an educational booklet about caregiving in addition to usual care by their doctors and nurses. The caregiver also completes surveys about his or her emotions, distress, confidence as a care giver, and quality of life. In addition, the study asks the caregiver questions about his or her age, race, ethnicity, marital status, employment status, education, annual household income, and current living arrangements. This pilot study will only be offered at the Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Main Campus.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: In-person education sessions
  • Behavioral: NCI Booklet
  • Other: Survey
  • Other: Interview
N/A

Detailed Description

Aim 1: Conduct a pilot test of the effects of a novel caregiver intervention, as compared to a control group, on family caregiver self-efficacy for caregiving, anxiety, depression, and health-related quality of life.

Aim 2: Explore the acceptability of a caregiver intervention that utilizes simulation.

Aim 3: Assess the feasibility of the intervention. Aim 4: Describe the incidence of patient events that may be impacted by caregiver self-efficacy, such as acute care visits, admissions to the hospital, visits to the emergency department, need for fluids in the radiation oncology department, and interrupted treatment course.

Study Design

Study Type:
Interventional
Actual Enrollment :
18 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Building Family Caregiver Skills Using a Simulation-based Intervention for Care of Patients With Head and Neck Cancer
Actual Study Start Date :
Aug 1, 2015
Actual Primary Completion Date :
Jan 12, 2018
Actual Study Completion Date :
Jan 12, 2018

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention Group: Caregiver education

The intervention includes caregivers who will receive an education and support program throughout radiation treatment in addition to usual care by their doctors and nurses.

Behavioral: In-person education sessions
The intervention will be delivered by a radiation oncology nurse. Each of the four in-person sessions consists of approximately 30 minutes of educational content/simulation that addresses a specific caregiving topic and any issues or concerns that the caregiver may be experiencing.
Other Names:
  • intervention group
  • educational content/simulation
  • Other: Survey
    written, qualitative assessments of areas including depression and anxiety, caregiver self-efficacy, care-giver self efficacy for head and neck cancer, health-related quality of life, patient performance status, demographics, and medical history.

    Other: Interview
    A structured series of open-ended questions will be used during a telephone interview with participants at four weeks post radiation treatment.
    Other Names:
  • semi-structured interview
  • Open ended questions
  • Active Comparator: Control Group: educational booklet

    The control group will receive an educational booklet about caregiving in addition to usual care by their doctors and nurses

    Behavioral: NCI Booklet
    Radiation Oncology Nurse will hand participant the NCI booklet
    Other Names:
  • When Someone You Love is being Treated for Cancer
  • Other: Survey
    written, qualitative assessments of areas including depression and anxiety, caregiver self-efficacy, care-giver self efficacy for head and neck cancer, health-related quality of life, patient performance status, demographics, and medical history.

    Other: Interview
    A structured series of open-ended questions will be used during a telephone interview with participants at four weeks post radiation treatment.
    Other Names:
  • semi-structured interview
  • Open ended questions
  • Outcome Measures

    Primary Outcome Measures

    1. Average efficacy of caregiving summary score [Up to 5 weeks]

      Summary statistics as well as observed values of longitudinally measured efficacy outcome variables (efficacy for caregiving, anxiety, depression, and HRQOL) will be presented graphically. Linear mixed models will be used to estimate within- and between-subject components of variance needed for design of a larger trial with these endpoints.

    2. Average anxiety summary score [Up to 5 weeks]

      Summary statistics as well as observed values of longitudinally measured efficacy outcome variables (efficacy for caregiving, anxiety, depression, and HRQOL) will be presented graphically. Linear mixed models will be used to estimate within- and between-subject components of variance needed for design of a larger trial with these endpoints.

    3. Average depression summary score [Up to 5 weeks]

      Summary statistics as well as observed values of longitudinally measured efficacy outcome variables (efficacy for caregiving, anxiety, depression, and HRQOL) will be presented graphically. Linear mixed models will be used to estimate within- and between-subject components of variance needed for design of a larger trial with these endpoints.

    4. Average Health Related Quality of Life (HRQOL) summary score [Up to 5 weeks]

      Summary statistics as well as observed values of longitudinally measured efficacy outcome variables (efficacy for caregiving, anxiety, depression, and HRQOL) will be presented graphically. Linear mixed models will be used to estimate within- and between-subject components of variance needed for design of a larger trial with these endpoints.

    Secondary Outcome Measures

    1. Qualitative assessment of acceptability [Up to 5 weeks]

      Descriptive statistics will be used to summarize responses to semi-structured interviews

    2. Attrition rate to assess feasibility [Up to 5 weeks]

      Feasibility will be assessed via attrition and consent rates.

    3. Consent rate to assess feasibility [Up to 5 weeks]

      Feasibility will be assessed via attrition and consent rates.

    4. Total time for delivering intervention to assess costs [Up to 5 weeks]

      Time for delivering the intervention will be recorded to aid in assessing costs.

    5. Average missed checklist items to assess integrity of intervention [Up to 5 weeks]

      Integrity of the intervention will be assessed through monitoring of intervention checklist.

    6. Event rate for patient events [Up to 5 weeks]

      Describe the average incidence of all patient events that may be impacted by caregiver self-efficacy. Events may include acute care visits, admission to the hospital, visits to the emergency department, need for fluids in the radiation oncology department, and interrupted treatment course, and others

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • family member or friend of an adult patient with a new diagnosis of Stage III - IV cancers of the tongue, gum, oral cavity, nasopharynx, oropharynx, hypopharynx, larynx, or parotid who is receiving radiation therapy for curative intent

    • identified by the patient as his/her primary caregiver who is providing daily assistance and/or emotional support

    • cognitively intact, as evidenced by orientation to person, place, and time

    • ability to speak, read, and comprehend English

    Exclusion Criteria:
    • Caregivers of patients who are receiving hospice care will be excluded because of the patient's poor prognosis and multiple issues associated with end-of-life care

    • Caregivers who are themselves undergoing active cancer treatment will be excluded (hormonal treatment allowed)

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center Cleveland Ohio United States 44106

    Sponsors and Collaborators

    • Case Comprehensive Cancer Center

    Investigators

    • Principal Investigator: Susan Mazanec, PhD, RN, University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Case Comprehensive Cancer Center
    ClinicalTrials.gov Identifier:
    NCT02577237
    Other Study ID Numbers:
    • CASE2315
    First Posted:
    Oct 16, 2015
    Last Update Posted:
    Feb 11, 2019
    Last Verified:
    Feb 1, 2019
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Case Comprehensive Cancer Center
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Feb 11, 2019